GlobalData on MSN22h
Boehringer seeks approval of lung disease drug after second Phase III successBoehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...
FIBRONEER™-ILD was a double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nerandomilast ...
Boehringer Ingelheim India and EMRI Green Health Services a GVK Enterprise Sign MoU to Transform Pre-hospital Stroke Care in India ...
Topline data from FIBRONEER-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change from baseline in forced vital capacity [mL] at week 52 vers ...
Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.
This puts it ahead of rivals Bayer and the GSK-Novartis joint venture, even though Boehringer has held on to its China consumer health business; the German company knows this is one of the best ...
In an editorial, J. Mocco, MD, of Mount Sinai Health System in New York City, characterized the DISTAL and ESCAPE-MeVO ...
Hall of Fame safety Brian Dawkins, who played with the Eagles and worked with Andy Reid and Steve Spagnuolo, gets into the matchups for Super Bowl LIX.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback